Researchers at Weill Cornell Medicine and NewYork-Presbyterian have discovered a function of the protein adipsin that could help inform new treatments for type 2 diabetes.
A protein that breast, lung and other cancers use to promote their spread – or metastasis – to the brain, has been identified by a team led by Weill Cornell Medicine and NewYork-Presbyterian investigators.
Cornell President Elizabeth Garrett heralded a future of greater collaboration between Ithaca and New York City at a Sept. 21 reception in honor of her inauguration as the university’s 13th president.
On May 19, four student start-up teams won $100,000 pre-seed funding and one year of co-working space in the Tata Innovation Center on Roosevelt Island.
Benefits open enrollment for endowed faculty and staff begins Friday, Nov. 1, and ends at 4 p.m. EST, Friday, Nov. 29, for coverage effective Jan. 1, 2020.
The state Capitol building in Albany was awash in Cornell red on Jan. 27 as state Senate and Assembly members welcomed more than 50 Cornell Cooperative Extension directors from across the state.
A makeathon to develop affordable assistive technology for people with disabilities, sponsored by Cornell, will be held April 21-23 at the Brooklyn Navy Yard.
An FDA-approved drug that has been in clinical use for more than 70 years may protect against lung injury in severe COVID-19 cases, according to a preclinical study from researchers at Weill Cornell Medicine and Cold Spring Harbor Laboratory.
How individuals, and health care professionals, deal with infection from SARS-CoV-2, the virus that causes COVID-19, varies depending on the severity of the infection.